EU Outsources Key Tobacco Control Responsibilities to Third Parties

Feb.27.2023
EU Outsources Key Tobacco Control Responsibilities to Third Parties
The EU outsources tobacco control responsibilities to non-elected bodies, causing concerns over accountability and potential conflicts of interest.

The European Tobacco Harm Reduction Advocates (ETHRA) has stated that the EU has outsourced key responsibilities for tobacco control to unelected organizations. ETHRA coordinates the actions of consumer groups and advocacy organizations throughout Europe. The organization warns that this has raised concerns about accountability and potential conflicts of interest.


EU officials had issued a tender notice for the "Support Action for the Tobacco Control Sector Single Framework Contract" earlier. Recently, they announced that the process has been completed and three contractors have been appointed.


The Spanish research and consultancy firm, Open Evidence, ...


The European Network for Smoking Prevention (ENSP)


Crete University


ETHRA has released a publicly available report which states that as part of their contribution, they will lead an "international consortium". This consortium will include the UK's ICF consultancy company, Brussels-based Milieu legal and policy consultancy, and Vital Strategies funded by Michael Bloomberg.


According to the Consumer Association, the contract will last for four years and is worth 3 million euros (approximately 22.03 million yuan).


According to the statement from ETHRA, the contractor's job will include:


Gather scientific literature, research, or clinical evaluations related to one or more tobacco or nicotine themes.


2. Statistical, market, and measurement analyses related to one or more tobacco or nicotine themes.


Tobacco Control Policy Model,


Behavioral research and analysis of specific issues.


Support for comprehensive health warnings,


Support for tobacco and related product labelling and packaging.


7. Restrictions on ingredients and related content/emission standards.


Support technological investment in information system development.


Conduct a legal assessment for the tobacco control measures of the European Union, countries, and international organizations.


The European Tobacco Harm Reduction Advocates (ETHRA) stated that the introductory notes in the tender specifications of the European Health and Digital Executive Agency (HaDEA) provide the legislative background of the EU's tobacco control policies, with the goal of achieving a "smoke-free tobacco generation" by 2040.


To achieve this goal, the plan is to revise the Tobacco Products Directive, which includes measures such as "implementing plain packaging and banning flavors in a completely transparent manner, improving the evaluation of ingredients through existing EU institutions, expanding taxes to new tobacco products, and addressing tobacco advertising, promotion, and sponsorship on the internet and social media.


According to the author of the document, there are concerns about the regulatory framework of the European Union. Currently, there is no systematic approach to dealing with all new tobacco and emerging products, and there is also a lack of flexibility to address rapidly developing products.


Advocates for reducing the harm of tobacco in Europe say, "This appears to be a daunting task for contractors. More importantly, it signifies that the policy-making responsibilities of the European Commission are now being outsourced to third parties. Accountability issues arise as well: when EU member states receive proposals to amend existing legislation, how do they know which proposals come from responsible officials and what role external actors played in shaping EU legislation?


Another issue is the potential conflict of interest with the winning bidder group. Of course, when it comes to the tobacco industry, they have a responsibility to declare that they have no conflict of interest in the tobacco industry. However, their work may have potential conflicts with other industries, such as the pharmaceutical industry that we may not be aware of.


References:


Efforts to Lobby on Behalf of Tobacco Industry The European Union (EU) has been found to be subcontracting its efforts to control tobacco, potentially undermining efforts to combat smoking. Investigations have discovered that the EU is employing companies which have links to the tobacco industry, leading to allegations of lobbying on behalf of the sector. The subcontractors are tasked with implementing tobacco control policies to be carried out across EU member states. Critics have voiced concern that this conflict of interest could threaten progress in reducing rates of smoking across Europe.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
Product | VAPORESSO Launches PRIX MTL Pod, With NFC Version Linking Interchangeable Panels to On-Screen Animations
Product | VAPORESSO Launches PRIX MTL Pod, With NFC Version Linking Interchangeable Panels to On-Screen Animations
VAPORESSO introduced the PRIX MTL pod system in August 2026 in two versions, Filter and NFC. The Filter version allows users to switch between a conventional drip tip and a filter tip, while the NFC version links interchangeable panels to matching on-screen animations. PRIX features a 2,600mAh battery, a 5.5ml pod, a 0.87-inch TFT display and a maximum output of 40W, alongside Dual Mesh Impact Pods capable of operating at two resistance and power configurations. VAPORESSO's French website lists MSRP at $39.99 for the Filter version and $49.90 for the NFC version.
Market
Aug.24 by 2Firsts Perspectives
Product | DOJO Launches BLAST10K Fresh in UK With 0+10ml E-Liquid Structure, Retaining 2+8ml Pod Compatibility
Product | DOJO Launches BLAST10K Fresh in UK With 0+10ml E-Liquid Structure, Retaining 2+8ml Pod Compatibility
DOJO launched the BLAST10K Fresh in the UK on September 4, 2026, introducing its INSTA-JUICED™ technology and a new 0+10ml structure that keeps e-liquid separated from the coil before activation. The device features a 1000mAh rechargeable battery, COREX BLAST dual-mesh technology and SSS leak-resistant technology, with a manufacturer-rated capacity of up to 10,000 puffs. It also retains compatibility with existing 2+8ml pods across the BLAST ecosystem. The launch introduces eight new flavors, including Matcha Strawberry, which DOJO describes as an industry first.
Market
Sep.04
Product | Philip Morris Korea Launches TEREA Limona Pearl, Expanding Fresh Blend Capsule Lineup to Five
Product | Philip Morris Korea Launches TEREA Limona Pearl, Expanding Fresh Blend Capsule Lineup to Five
Philip Morris Korea launched TEREA Limona Pearl in South Korea on August 31, 2026, expanding the TEREA Fresh Blend capsule tobacco stick lineup from four variants to five. Designed for the IQOS ILUMA series, the new stick combines a capsule with what the company calls a Fresh Filter. Philip Morris Korea describes the product as offering an aromatic, refreshing flavor profile with a cooling sensation, with an additional fresh note released when the capsule is crushed. The recommended retail price is KRW 4,800 per pack, with sales through IQOS stores and convenience stores nationwide. No reliable evidence has been found that the same Limona Pearl SKU was previously officially launched in another major IQOS market.
Sep.01
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
A federal judge in Texas on Oct. 8 granted a joint request by the FDA and plaintiffs including Altria subsidiaries Helix Innovations and NJOY to stay litigation challenging the agency's 2021 PMTA rule. The court cited FDA's anticipated rulemaking concerning the regulation at issue. FDA announced on Sept. 28 that it intends to reassess the PMTA framework and could initiate new rulemaking to replace it. The parties must file a joint status report within 45 days and every 45 days thereafter. A motion by three Reynolds American companies to intervene remains pending.
Regulations
Oct.10
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08